Wound dehiscence rates decreased in reconstructive surgery of anorectal malformations after introduction of a standardized postoperative treatment program
(2025) In World Journal of Pediatric Surgery 8(3).- Abstract
Background Wound dehiscence is a known complication after anorectal malformations (ARMs) surgery. The aim was to evaluate if a standardized post-posterior sagittal anorectoplasty (PSARP) treatment program decreased wound dehiscence rates. Methods Wound dehiscence rates within 30 days post-PSARP were compared in a case-control single-center study between patients with a standardized post-PSARP treatment 2017-2023, and a cohort with a non-standardized management 2001-2016. The standardized post-PSARP program comprised a minimum of 3 days of: intravenous antibiotics imipenem+cilastatin (with optional subsequent oral amoxicillin+clavulanic acid+metronidazole), fasting after primary PSARP (no stoma), urinary catheter and regular wound... (More)
Background Wound dehiscence is a known complication after anorectal malformations (ARMs) surgery. The aim was to evaluate if a standardized post-posterior sagittal anorectoplasty (PSARP) treatment program decreased wound dehiscence rates. Methods Wound dehiscence rates within 30 days post-PSARP were compared in a case-control single-center study between patients with a standardized post-PSARP treatment 2017-2023, and a cohort with a non-standardized management 2001-2016. The standardized post-PSARP program comprised a minimum of 3 days of: intravenous antibiotics imipenem+cilastatin (with optional subsequent oral amoxicillin+clavulanic acid+metronidazole), fasting after primary PSARP (no stoma), urinary catheter and regular wound cleansing. Results A total of 149 patients (61% males) with various ARM subtypes were included of which 51% were reconstructed with stomas. Overall, wound dehiscence developed in 8 of 59 patients (14%) in the standardized post-PSARP program group versus 28 of 90 patients (31%) in the control group (p=0.014). In primary PSARPs (no stoma, 59% males), wound dehiscence developed in 6 of 33 patients (18%) in the standardized post-PSARP program group versus 17 of 40 patients (43%) in the control group (p=0.026). Conclusion Wound dehiscence rates may be reduced using a standardized post-PSARP treatment program.
(Less)
- author
- Tofft, Louise
LU
; Granéli, Christina
LU
; Hagelsteen, Kristine
LU
; Wester Fleur, Matilda
LU
and Stenström, Pernilla
LU
- organization
- publishing date
- 2025-06-08
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Colorectal Surgery, Congenital Abnormalities, Disabled Children, Patient Outcome Assessment, Pediatrics
- in
- World Journal of Pediatric Surgery
- volume
- 8
- issue
- 3
- article number
- e001003
- publisher
- BMJ Publishing Group
- external identifiers
-
- pmid:40519536
- scopus:105007735916
- ISSN
- 2516-5410
- DOI
- 10.1136/wjps-2025-001003
- language
- English
- LU publication?
- yes
- additional info
- Publisher Copyright: © Author(s) (or their employer(s)) 2025.
- id
- b9e1daf0-bc56-469d-be39-00029e49b2c5
- date added to LUP
- 2025-11-29 01:02:31
- date last changed
- 2025-12-13 02:38:57
@article{b9e1daf0-bc56-469d-be39-00029e49b2c5,
abstract = {{<p>Background Wound dehiscence is a known complication after anorectal malformations (ARMs) surgery. The aim was to evaluate if a standardized post-posterior sagittal anorectoplasty (PSARP) treatment program decreased wound dehiscence rates. Methods Wound dehiscence rates within 30 days post-PSARP were compared in a case-control single-center study between patients with a standardized post-PSARP treatment 2017-2023, and a cohort with a non-standardized management 2001-2016. The standardized post-PSARP program comprised a minimum of 3 days of: intravenous antibiotics imipenem+cilastatin (with optional subsequent oral amoxicillin+clavulanic acid+metronidazole), fasting after primary PSARP (no stoma), urinary catheter and regular wound cleansing. Results A total of 149 patients (61% males) with various ARM subtypes were included of which 51% were reconstructed with stomas. Overall, wound dehiscence developed in 8 of 59 patients (14%) in the standardized post-PSARP program group versus 28 of 90 patients (31%) in the control group (p=0.014). In primary PSARPs (no stoma, 59% males), wound dehiscence developed in 6 of 33 patients (18%) in the standardized post-PSARP program group versus 17 of 40 patients (43%) in the control group (p=0.026). Conclusion Wound dehiscence rates may be reduced using a standardized post-PSARP treatment program.</p>}},
author = {{Tofft, Louise and Granéli, Christina and Hagelsteen, Kristine and Wester Fleur, Matilda and Stenström, Pernilla}},
issn = {{2516-5410}},
keywords = {{Colorectal Surgery; Congenital Abnormalities; Disabled Children; Patient Outcome Assessment; Pediatrics}},
language = {{eng}},
month = {{06}},
number = {{3}},
publisher = {{BMJ Publishing Group}},
series = {{World Journal of Pediatric Surgery}},
title = {{Wound dehiscence rates decreased in reconstructive surgery of anorectal malformations after introduction of a standardized postoperative treatment program}},
url = {{http://dx.doi.org/10.1136/wjps-2025-001003}},
doi = {{10.1136/wjps-2025-001003}},
volume = {{8}},
year = {{2025}},
}